Myelofibrosis Treatment in Turkey

What Is Myelofibrosis and What Are Its Symptoms?

Myelofibrosis is a rare type of chronic blood cancer belonging to a group of conditions called myeloproliferative neoplasms. In a healthy body, bone marrow produces a balanced supply of blood cells. In myelofibrosis, genetic mutations—most commonly in the JAK2, CALR, or MPL genes—cause abnormal blood stem cells to proliferate. This leads to progressive scarring (fibrosis) inside the bone marrow, disrupting normal blood cell production.

As the bone marrow becomes increasingly fibrous, the spleen and liver often step in to produce blood cells, a process called extramedullary haematopoiesis. This frequently causes significant enlargement of the spleen (splenomegaly). Patients seeking an evaluation through oncology services commonly report:

• Severe, persistent fatigue and pale skin resulting from progressive anaemia
• Abdominal fullness, discomfort, or early satiety caused by an enlarged spleen pressing on the stomach
• Frequent night sweats, low-grade fevers, and unintentional weight loss
• Easy bruising or unusual bleeding due to low platelet counts (thrombocytopenia)
• Bone or joint pain, along with an increased susceptibility to recurrent infections

How Is Myelofibrosis Diagnosed in Turkey?

An accurate diagnosis requires a comprehensive evaluation by a specialist haematologist. When visiting a Turkish clinic for a complex evaluation or initial consultation through check-ups and diagnostics, specialists perform advanced testing to confirm the diagnosis and assess disease risk.

Standard diagnostic procedures typically involve:

• Full Blood Count (FBC) and Peripheral Blood Smear: To examine blood cell counts and identify characteristic teardrop-shaped red blood cells (dacryocytes) and immature cells.
• Bone Marrow Aspiration and Biopsy: A crucial test where bone marrow fluid and solid tissue are extracted—usually from the pelvic bone—to evaluate the degree of marrow fibrosis under a microscope.
• Cytogenetic and Molecular Testing: Polymerase chain reaction (PCR) or next-generation sequencing to detect specific gene mutations such as JAK2 V617F, CALR, or MPL.
• Abdominal Imaging: Ultrasound or CT scans to precisely measure spleen and liver volume.

International patients should bring all existing medical records, including previous blood test histories, formal biopsy slide reports or paraffin blocks, genetic test results, and recent abdominal imaging to avoid unnecessary duplicate testing.

Treatment Options and Clinical Approaches

Treatment for myelofibrosis is tailored to the patient's dynamic international prognostic scoring system (DIPSS) risk category, overall health, and symptoms. Because therapies range from supportive management to intensive interventions, the medical team carefully evaluates each individual before recommending a pathway.

Surgical removal of the spleen (splenectomy) or low-dose radiation therapy to the spleen may occasionally be considered under specialized care, such as general surgery consultation, if targeted drugs fail to control severe abdominal pain.

Planning Your Medical Travel to Turkey

Travelling abroad for a complex haematological condition requires careful coordination. Prior to departure, your complete medical dossier is reviewed by a haematology team in Turkey to determine whether further diagnostic testing or immediate clinical intervention is appropriate.

Patients travelling for diagnostic workups or medical management should plan to stay in Turkey for at least 10 to 14 days. If an allogeneic stem cell transplantation is recommended, the treatment stay is considerably longer, often requiring several months of inpatient care and close outpatient monitoring. Before returning home, a detailed discharge plan must be established with your domestic haematologist to manage ongoing blood transfusions, prescription refills, and routine blood monitoring.

When Travel Is Not Advisable and Emergency Signs

Long-distance travel is not safe for every patient. You should delay international travel if you have severe, unstable anaemia, active systemic infections, dangerously low platelet counts with active bleeding, or acute organ dysfunction.

Seek immediate emergency medical attention locally if you experience any of the following warning signs:

• Sudden, severe abdominal pain, which may indicate splenic infarction or rupture
• High fever, severe chills, or signs of an active infection
• Uncontrolled bleeding, severe nosebleeds, or vomiting blood
• Shortness of breath, chest pain, or extreme lightheadedness
• Sudden weakness, confusion, or visual disturbances